| Literature DB >> 10692239 |
H Swiniarski1, S F Wolf, K Sturmhoefel, R L Peterson, A J Dorner, M O'Toole.
Abstract
The effect of in vivo administration of rmIL-12 on the CTL response to immunization with a weakly immunogenic class I-restricted peptide emulsified in incomplete Freund's adjuvant was investigated. In the absence of IL-12, peptide-specific CTL responses were significantly greater following coimmunization with class I-restricted peptide and T helper cell antigens than following immunization with the class I-restricted peptide alone. IL-12-dependent enhancement of the CTL response to peptide immunization was demonstrated in the presence of, but not in the absence of, coimmunization with T helper cell antigen. These findings indicate that IL-12 enhancement of the CTL response to weak class I-restricted immunogens is T helper cell dependent. Treatment with rmIL-12 also enhanced the CTL response to immunization with cDNA encoding both CTL and T helper cell epitopes. These findings are relevant to the design of vaccines containing tumor-associated class I-restricted peptides currently being tested as an immunotherapy for cancer patients. Copyright 2000 Academic Press.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10692239 DOI: 10.1006/clim.2000.4836
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969